TNFα is known to increase the activity of the canonical NFκB pathway in conditions associated with muscle weakness, including sepsis, cancer, and ageing [36-39] and to cause protein degradation in cultured myotubes [5,6]. The gene discussed is NFKB1; the disease is cancer.